LAURA STEVENSON: Open Payments
NPI 1437116639 · VALENCIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,412 in 52 payments from 17 companies in 2025. Trend: 2023 $1,885 · 2024 $2,479 · 2025 $1,412
Food & beverage: $1,412
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 10 | $387 |
| Janssen Biotech, Inc. | 5 | $225 |
| Regeneron Healthcare Solutions, Inc. | 6 | $207 |
| Arcutis Biotherapeutics, Inc. | 4 | $75 |
| Organon LLC | 4 | $74 |
| ABBVIE INC. | 3 | $69 |
| UCB, Inc. | 3 | $63 |
| Lilly USA, LLC | 3 | $61 |
| Incyte Corporation | 3 | $53 |
| PFIZER INC. | 2 | $38 |
Products named: DUPIXENT, TREMFYA, Zoryve, Bimzelx, TALTZ, VTAMA, RINVOQ, OPZELURA.
Industry payments across CA — which companies pay providers there.
